Quick jump to page content
Main Navigation
Main Content
Sidebar
Register
Login
Toggle navigation
Home
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Current
Archives
Submission
Search
Search
Search articles for
Advanced filters
Published After
2017
2018
2019
2020
2021
2022
January
February
March
April
May
June
July
August
September
October
November
December
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Published Before
2017
2018
2019
2020
2021
2022
January
February
March
April
May
June
July
August
September
October
November
December
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
By Author
Search Results
Efficacy and safety of tralokinumab plus topical corticosteroids in patients with severe atopic dermatitis and prior history of dupilumab treatment: a post hoc subgroup analysis from ECZTRA 7 trial
Jan Gutermuth, Andrew Pink, Margitta Worm, Lise Soldbro, Thomas Mark, Joshua Corriveau, Christian Bjeeregard Oland, Stephan Weidinger
Page s60
Poster PDF
Use of Topical Corticosteroids with Tralokinumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial
Jonathan Silverberg, Andrew Pink, Christina Olsen, Stephan Weidinger
Page s99
Poster PDF
Efficacy and Safety of Tralokinumab with Concomitant Topical Corticosteroids in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of the ECZTRA 3 Trial
Boni E. Elewski, Matthew J. Zirwas, Richard G. Langley, Andrew F. Alexis, Karen A. Veverka, John Zoidis, Azra Kurbasic, Jonathan I. Silverberg
Page s97
Poster PDF
Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial
Stephan Weidinger, Jonathan Silverberg, Darryl Toth, Thomas Bieber, Andrew Alexis, Boni Elewski, Andrew Pink, DirkJan Hignen
Page s102
Poster PDF
1 - 4 of 4 items
×
Modal Header
